EstelleS.HarrisMD

Pulmonology • Salt Lake City, UT

Critical Care Medicine, Pleural Disease

Associate Professor of Medicine Co-Director Medical ICU

Join to view full profile

Dr. Harris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Harris' full profile

Already have an account?

Office
50 N Medical Dr
Salt Lake City, UT 84132
Phone+1 801-581-7806

Education & Training

University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
Boston University Medical CenterResidency, Internal Medicine, 1988 - 1991
University of Colorado School of Medicine Anschutz Medical CampusClass of 1988

Certifications & Licensure

UT State Medical License 1996 - 2026
MI State Medical License 1991 - 1998
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Clinical Trials

Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. Start of enrollment: 2020 Apr 02
Terminated
Phase 2, Phase 3

Publications & Presentations

PubMed

4 citations
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Samuel M Brown, Christina E Barkauskas, Birgit Grund, Shweta Sharma, Andrew N Phillips
The Lancet. Respiratory Medicine. 2023-09-01
7 citations
Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, ...
Robert Paine, Robert Chasse, E Scott Halstead, Jay Nfonoyim, David J Park
Military Medicine. 2023-07-22
17 citations
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial.
Wesley H Self, Allison P Wheeler, Thomas G Stewart, Harry Schrager, Jason Mallada
Chest. 2022-11-01

Press Mentions

Hospitals in Rocky Mountain States Struggling to Keep up with Coronavirus SurgeOctober 28th, 2020
Latest Booster Reduces Adults’ Risk of Moderate or Severe COVID by More Than HalfMarch 3rd, 2024

Grant Support

Lymphocyte Adhesion And Pulmonary InflammationNational Heart, Lung, And Blood Institute1997–2001